Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Japiassu RM et al. - The patient underwent treatment with infliximab intravenously for his systemic condition. Regression of the vasoproliferative tumors in both eyes and improvement of macular edema in the left eye was observed. Although the data are limited, anti-TNF antibodies such as infliximab may be useful in the treatment of retinal vascular tumors.


Previous Article Next Article

Today in Clinical Pharmacology...keeping you current

Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes
New England Journal of Medicine, 07/02/09

Prospective Randomized Comparison of 1-Day and 3-Day Application of Topical 0.5% Moxifloxacin in Eliminating Preoperative Conjunctival Bacteria
Journal of Ocular Pharmacology and Therapeutics, 06/04/09

Tachyphylaxis after intravitreal bevacizumab for exudative age-related macular degeneration
Retina, 06/11/09

Today in Retina...keeping you current

Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes
New England Journal of Medicine, 07/02/09

Tachyphylaxis after intravitreal bevacizumab for exudative age-related macular degeneration
Retina, 06/11/09

Odds of abuse associated with retinal hemorrhages in children suspected of child abuse
Journal of American Association for Pediatric Ophthalmology and Strabismus , 06/26/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address